Humedix to Sign an Exclusive Sales Agreement for Reedle Booster for Hospitals and Clinics
전체 맥락을 이해하기 위해서는 본문 보기를 권장합니다.
Evov Therapeutics CEO Park Byung kook said "Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value."
Humedix CEO Kang Min jong said "Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line."
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
[Shin-Min Joon, Edaily Reporter] Humedix of Huons Group strengthened its aesthetics portfolio by securing commercialization rights for Reedle Booster in Korea.

The Reedle Booster co developed by VT Cosmetics (hereafter VT) and Evov Therapeutics, is an exclusive product made for use in hospitals and clinics, leveraging the popularity of VT’s Reedle Shot in the global aesthetics market. Compared to injectable skin booster treatments, Reedle Booster procedure offers minimal pain and a shorter recovery time, allowing for a faster return to daily life after the treatment. It also provides immediate improvement in skin vitality.
With VT’s proprietary RED REEDLE™ channeling technology Reedle Booster creates micro-channels on the skin surface, facilitating delivery of active ingredients deep into the dermal layer.
Through this agreement Humedix has secured the exclusive commercialization rights in Korea for Reedle Booster EX and Reedle Booster PN, which contain next generation plant derived exosomes and small molecule polynucleotides (PN) as their respective active ingredients. Humedix plans to expand its presence in the aesthetics market by focusing on distribution to hospitals and clinics specializing in aesthetics including dermatology and plastic surgery.
Evov Therapeutics CEO Park Byung kook said “Through our partnership with Humedix which has established a strong foothold in aesthetics market in Korea Evov Therapeutics plans to promote the technological prowess of Reedle Booster and maximize its brand value.”
Humedix CEO Kang Min jong said “Reedle Booster is a professional product that started from the brand awareness and consumer needs of the Reedle Shot that has already achieved great success in K-beauty market. We have strengthened our product portfolio with new additions such as this treatment solution targeting the epidermis layer differentiated from our existing product line.”
신민준 (adonis@edaily.co.kr)
Copyright © 이데일리. 무단전재 및 재배포 금지.
- '여친 사망' 확인하러 갔나...26세 장재원 신상 공개
- “숙박할인권 쓰러가자”…李정부, 숙박상품 80만장 쏜다
- "성폭행 중 미성년 피해자 母에 발각"…충주시 공무원, 나이 속여 접근
- “연차 없이 10일 쭉 쉰다”…10월 10일 임시공휴일 지정 ‘관심’
- 김상욱 “윤미향, ‘나쁜사람’인 줄 알았는데…팩트 달랐다”
- "가방이 피로 흥건"...아파트 산책하다 '으악'
- 정은혜♥조영남 부부, 2세 계획 공개…"혼인신고 다시 해"
- 안철수, 장동혁 겨냥 "친길계 후보냐"…김문수엔 "정말 경악"
- 김나영, 이관희 패션 조언…"마이큐♥ 옷 가져왔다" (옷장전쟁)
- 英 배우 엠마 톰슨 "이혼한 날 트럼프가 데이트 신청"…27년 전 무슨 일?